Thursday, March 17, 2022
Wednesday, March 16, 2022
Friday, March 11, 2022
Investor Ideas #Potcasts 627, #Cannabis News and #Stocks on the Move- Interview with CEO of Juva Life (CSE: $JUVA.C) (OTCQB: $JUVAF)
Investor Ideas #Potcasts 627, #Cannabis News and #Stocks on the Move- Interview with CEO of Juva Life (CSE: $JUVA.C) (OTCQB: $JUVAF)
Delta, Kelowna, BC, March 11, 2022 (Investorideas.com Newswire), investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2022/031122-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2022/cannabis-potcasts/03111Interview-JUVA.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
In today’s podcast Investorideas interviews Doug Chloupek, CEO of Juva Life Inc. (CSE: JUVA) (OTCQB:JUVAF) a cannabis cultivation and life sciences company aimed of unlocking the secret of pain management, where we discussed the company’s recent filing of a patent application with the United States Patent and Trademark Office (USPTO) on JUVA-041, a small molecule isolated from the cannabis plant that has been identified by Juva’s in-house research team, the potential applications of such small molecules, as well as where the industry is heading with regards to cannabinoid based research.
When asked about what helps differentiate Juva Life from other cannabinoid life sciences companies Chloupek commented, “Juva is a life science research company with heavy interest and focus on pharmaceutical new drug developments, specifically with small molecules targeting inflammation and unlocking the mysteries of cannabis. With that we have another arm of the company which really participates in the cannabis sector, so cultivation, distribution and delivery, and that’s really what supplies the revenue for the real fun of the company which is it’s life science portion.”
Chloupek went on to discuss his perspective on how the potential upside for the small molecules and life sciences portion of Juva far outweighs the strictly cannabis side of the industry saying, “what you have in the cannabis industry, with no disrespect to the cannabis industry because that’s where I come and that’s been my livelihood for over a decade, is you have thousands of companies and brands fighting for peanuts. When you’re looking at the pharmaceutical side of the industry it is almost largely untapped, besides a couple of multi-billion dollar acquisitions which have occurred of the last 12 months, and every single one of them are looking anxiously on the sidelines for how they can participate, but they can’ts because of federal restrictions, how they can get in, but they can’t because of regulatory burdens, and then you have Juva, threading a very complicated process and pathway, creating a new way that you can achieve similar end goals. Unequivocally the value is in the pharmaceutical drug development, the API development.”
Juva currently has two main small molecule patents in the works, JUVA-019 and JUVA-041. For JUVA-019 the Company has filed a patent application and has conducted preclinical research showing that the compound is effective as a stand-alone compound in inhibiting inflammation by modulating certain biomarkers in the body. Through its research division, Juva scientists have continuously been evaluating an internally curated database of compounds found in the cannabis plant for their therapeutic benefit, leading to the identification of the two proprietary compounds: JUVA-019 and JUVA-041, which the Company has nominated as drug candidates for further preclinical investigation.
Speaking in more detail about the potential for these small molecules, Chloupek stated, “we have spent many many years and a lot of research, and I’ve put some of the smartest people in the world on a task, to understand the complexities of cannabis. How do you do that? How do you understand this complex plant that has thousands of different chemicals and identify down to what is the mode of action? We all know about the entourage effect which is the synergistic use of cannabinoids, terpenes and other chemical properties in cannabis which synergistically work together to create an effect on the human body. The question can then be asked, is there a particular single thing in the cannabis plant that we attribute as the entourage effect, or is it really necessary to have all of these other compounds synergistically working together? That's what distills down to the question of JUVA-019 and JUVA-041, is they are single molecule compounds found in cannabis, they are not terpenes, they are not cannabinoids they are not flavonoids, but they have been shown to be the key to the mode of action that regulates the pathways of inflammation in the human body found in cannabis.”
Chloupek continued, “So I can tell you for a fact, and this will be a mind blower for many listening, but THC and CBD, in relation to JUVA-041 and JUVA-019, hold little to no therapeutic value on inflammation in the human body, there is no added synergy, and for that matter combining THC or CBD or any other cannabinoids, downregulate the effectiveness of JUVA-019 and JUVA-041 down to the level of the respective cannabinoids. So they are exponentially more potent on their own, they regulate the cytokine pathways, and we are moving them through toxicology and safety through In Vivo right now.”
The company also recently announced the launch of the Company’s Journal App, designed to help cannabis users and patients track their consumption, and gain insight into how cannabis products affect their health and wellness.
“We’re proud to be one of the first and only companies to offer consumers a daily tracking solution that provides them a closer look at how their cannabis use affects their personal health and wellness,” said Doug Chloupek, CEO and Founder of Juva. “One of Juva’s primary goals is to expand our industry’s knowledge of the medicinal effects of cannabis from a scientific perspective. The Journal App provides a personal tracking solution for our customers and it gives Juva information that compliments the data we collect via our research registry.”
Choupek went on to discuss in more detail some of the potential applications of JUVA-019 and JUVA-041 within the medical community, how he sees Juva’s business model influencing the industry as whole and what’s next on the horizon for Juva LIfe.
To find out more information about Juva Life Inc. click here.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio , Google Podcasts and most audio platforms available.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research , guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
New #Stocks and #Trading Ideas: (CSE: $RR.C) (TSX.V: $QPM.V) (TSX.V: $DSV.V) (CSE: $PLCN.C) (NYSE: $BRCC) (NEO: PLBL)
New #Stocks and #Trading Ideas: (CSE: $RR.C) (TSX.V: $QPM.V) (TSX.V: $DSV.V) (CSE: $PLCN.C) (NYSE: $BRCC) (NEO: PLBL)
New #Mining, #Cannabis, #Beverage & #Health&Wellness Stocks to Watch
Vancouver, Kelowna, Delta, BC, March 11, 2022 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Mining, Cannabis, Beverage & Health & Wellness. Today’s stocks have been added to our lists of free stock directories in each sector.
Read this in full at https://www.investorideas.com/news/2022/main/03111Stocks.asp
The newest mining companies operate in North America, Mexico and Nicaragua and are involved in various mineral/precious metals explorations including green metals for the electric vehicle and fuel cell vehicle market.
The latest cannabis company provided edibles, while the newest beverage company is a veteran-founded coffee company.
The newest health and wellness company is a lifestyle intervention program using psychology, neuroscience and nutritional science.
New Stocks added to the Mining Stocks Directory:
Labrador Uranium Inc. (CSE:LUR) is engaged in the exploration and development of uranium projects in Labrador, Canada. The Company has acquired the Moran Lake and CMB Projects covering over 139,000 ha in the prolific Central Mineral Belt (CMB) in central Labrador and the Notakwanon Project in northern Labrador. Both the Moran Lake Project, which hosts historical uranium mineral resources, and the CMB Project, located adjacent to Paladin Energy’s Michelin uranium deposit, have had substantial past exploration work completed with numerous targets with uranium, copper and IOCG style mineralization. The Notakwanon Project is underexplored but drill ready. All three projects are expected to be the focus of an aggressive exploration program in 2022.
EON DISCOVERY GROUP, INC. (OTC PINK: CGLD) Formerly Buscar Company - is a mining operation that holds the rights to ten gold mining claims at Treasure Canyon located in Plumas County, California. More recently, the company has also acquired thirty additional claims in the Bucks Lake area of Northern California. Combined, Buscar company has a total of 800 acres of unpatented claims in Plumas National Forest, California.
Quebec Precious Metals Corporation (TSX.V:QPM) is a gold explorer with a large land position in the highly prospective Eeyou Istchee James Bay territory, Quebec, near Newmont Corporation's Éléonore gold mine. QPM's flagship project is the Sakami project with significant grades and well-defined drill-ready targets. QPM's goal is to rapidly explore the Sakami project and advance to the mineral resource estimate stage.
Discovery Silver (TSX.V:DSV) flagship project is its 100%-owned Cordero project, one of the world’s largest silver deposits. The PEA completed in November 2021 demonstrates that Cordero has the potential to be developed into a highly capital efficient mine that offers the combination of margin, size and scaleability. Cordero is located close to infrastructure in a prolific mining belt in Chihuahua State, Mexico. Continued exploration and project development at Cordero is supported by a strong balance sheet with cash of approximately C$70 million.
Sun Summit Minerals (TSX-V: SMN) is an exploration company focused on expanding its epithermal gold discovery at its flagship Buck Project located in north-central British Columbia. The Company is exploring multiple high priority targets through methodical, well-funded exploration campaigns with year-round drilling access. The Project has high-grade and bulk-tonnage gold, silver, and zinc potential and is located in an established mining region that includes many former operating mines and current exploration projects.
Sun Summit is committed to environmental and social responsibility with a focus on responsible development to generate positive outcomes for all stakeholders.
Sailfish Royalty (TSX.V:FISH) is a precious metals royalty and streaming company. Within Sailfish's portfolio are two main assets in the Americas: a gold stream equivalent to a 3% NSR on the San Albino gold mine (~3.5 sq. km) and a 2% NSR on the area (~134.5 sq. km) surrounding San Albino in northern Nicaragua; and an up to 3% NSR on the multi-million ounce Spring Valley gold project in Pershing County, Nevada.
Recharge Resources Ltd. (CSE:RR) is a Canadian mineral exploration company focused on exploring and developing the production of high-value battery metals to create green, renewable energy to meet the demands of the advancing electric vehicle and fuel cell vehicle market.
New Stocks added to the Cannabis Stocks Directory:
Cannibble Food-Tech Ltd. (CSE:PLCN) is a food tech company that develops and manufactures food mix products that are enhanced variously with hemp seeds, hemp protein, CBD, and THC, where legal to do so. Cannibble has developed proprietary formulas for powder-based edibles that are subsequently enhanced with active cannabinoids, which are marketed under our brand name “The Pelicann”. Cannibble has developed over 100 product SKUs, of which 32 have been manufactured to date.
New Stocks added to the Beverage Stocks Directory:
BRC Inc. (NYSE:BRCC) Black Rifle Coffee Company (BRCC) is a veteran-founded coffee company serving premium coffee to people who love America. Founded in 2014 by Green Beret Evan Hafer, Black Rifle develops their explosive roast profiles with the same mission focus they learned while serving in the military. BRCC is committed to supporting Veterans, active-duty military, first responders and the American way of life.
New Stocks added to the Health & Wellness Stocks Directory:
Plantable Health Inc. (NEO: PLBL) is a clinically-supported, lifestyle intervention program that combines behavioral psychology, neuroscience and nutritional science to transform health and wellness. Plantable drives healthy weight loss and an improvement in performance, health and well-being by bringing together whole food, plant-based meals, personalized coaching support and lifestyle educational tools to empower people to change their dietary habits.
The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast.
Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining and the AI Eye.
Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com
https://www.investorideas.com/Investors/Services.asp
Learn more about advertising and guest posts
https://www.investorideas.com/Advertise/
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
Tuesday, March 8, 2022
Investor Ideas #Potcasts 626, #Cannabis News and #Stocks on the Move- (Nasdaq: $HITI) (TSXV: $HITI.V) (TSX: $TBP.TO) (Nasdaq: $TLRY) (TSX: $TLRY.TO)
Investor Ideas #Potcasts 626, #Cannabis News and #Stocks on the Move- (Nasdaq: $HITI) (TSXV: $HITI.V) (TSX: $TBP.TO) (Nasdaq: $TLRY) (TSX: $TLRY.TO)
Delta, Kelowna, BC, March 8, 2022 (Investorideas.com Newswire), investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2022/030822-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2022/cannabis-potcasts/03081HITI-TBP-TLRY.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few public company announcements as well as industry related news.
In a recent CTV news article, starting today, Alberta has allowed private retailers to begin selling cannabis online, instead of having to go through the Alberta, Gaming, Liquor and Cannabis Commission (AGLC).
Private retailers will still need to apply for accreditation through the AGLC, use an age verification program and undergo a compliance check in order to sell and deliver cannabis products.
While the province has more than 750 cannabis stores, only five companies have received approval from the AGLC — permitting 74 locations to ship and sell online.
"There's several major players that are saying they're not going to make tomorrow's deadline," said John Pracejus, a University of Alberta professor and the academic director for the Centre for Cities and Communities.
"Alberta is requiring some things that other provinces that have moved to this model have not," he added. "The age verification programs are somewhat more stringent than other provinces."
Some independent retailers suggest online sales will not be a viable option, given some of the AGLC requirements.
"You're going to have to hire a delivery driver so that means an added wage, potentially gas, vehicle insurance, commercial liability," said Joshua Vera, owner of Elevate Cannabis.
"By the time you make your delivery, there's really no margin to be made and it's just not feasible," he added. "It's no favor to independent retailers."
The AGLC says it is exploring the option for third-party delivery companies like Uber Eats or Skip the Dishes to be allowed to offer cannabis. Third-party delivery companies started offering alcohol in 2020.
High Tide Inc. (Nasdaq: HITI) (TSXV: HITI), a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets, announced today that it has launched its cannabis Delivery on Demand program at select Canna Cabana locations in Alberta, as permitted by newly-implemented regulations which allow private sector cannabis retailers to offer delivery and e-commerce services as of today. Through the Company's Delivery on Demand program, customers will be guaranteed delivery within two hours of placing their order, or in any hourly time-slot chosen by the customer between 12:00pm and 8:00pm outside of the two hour window. The Company intends to further expand delivery services across its Alberta store network in the coming weeks.
"In allowing private sector-led cannabis e-commerce and home delivery, Alberta has shown its commitment to helping regulated cannabis retailers effectively compete against and drive out illicit market operators. By launching Delivery on Demand at Canna Cabana locations in Alberta, we can now offer our Cabana Club members in the province access to our unbeatable prices on cannabis and consumption accessories from the comfort of their own homes," said Raj Grover, President and Chief Executive Officer of High Tide. "Between our industry-leading prices and Delivery on Demand guarantee, we are able to offer a fantastic delivery experience for our Alberta customers, both existing and new. As the largest cannabis retailer in Alberta, the launch of delivery and e-commerce services will help to solidify our leadership position and gain further market share in the province," added Mr. Grover.
In a recent article from Cannabis Business Times, Israel, President Isaac Herzog and Justice Minister Gideon Sa’ar issued a special call March 6 to decriminalize personal use and expunge criminal records.
This will mean Israel will be decriminalizing adult-use cannabis before the U.S., its Western ally that also happens to be the largest cannabis hub in the world through a patchwork of state legalization.
While U.S. President Joe Biden has been busy putting policies in place to deny government security clearance to those who have invested in cannabis companies, the Israeli government is moving to approve regulations that would decriminalize adult-use cannabis and expunge criminal records for those with cannabis-related convictions.
Israel President Isaac Herzog and Justice Minister Gideon Sa’ar announced March 6 that those with cannabis convictions would be able to submit a request to have their records erased. In addition, individuals with pending criminal proceedings related to cannabis use or possession would be able to have their charges dropped.
The statement also said that Herzog and Sa’ar’s call comes out of a desire to erase the label of criminality and the “associated stain” from anyone with prior cannabis-related convictions.
“It must be emphasized that every request will be considered on its merits, according to its particular circumstances, on an individual basis, considering the above mentioned changes of policy and law,” their statement said.
The new regulations would not apply to individuals who were also charged with separate offenses alongside cannabis (except for possession of drug paraphernalia). The special call also clarifies that those who were soldiers or a minor at the time of their arrest would not be included in the expungement provisions.
Under the decriminalization components of the new regulations, minors, soldiers and police would still be charged as before, reported Haaretz, the longest running print newspaper in Israel. Otherwise, the maximum fine would be limited to 1,000 shekels, roughly US$300, for personal cannabis use.
The newspaper reported that Sa’ar is expected to sign the regulations in the coming days, and Israel’s unicameral parliament, Knesset, is anticipated to approve it. Immediate implementation would follow.
Tilray Brands, Inc. (Nasdaq: TLRY) (TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced the launch of Good Supply Hash Bats™, the brand's unique take on infused pre-rolls. Joining Good Supply's award-winning portfolio of cannabis products, Hash Bats™ is a smooth-smoking, hash-infused pre-roll that "hits hard." Unlike a standard cannabis pre-roll, Good Supply's Hash Bats™ is the perfect blend of our consumers' favorite strains, Jean Guy and Starwalker Kush, and hash magic for the perfect 'hit’.
"We're excited to introduce our take on infused pre-rolls to the Good Supply portfolio, which continues to provide our best-selling 'good weed' to Canadian consumers with its roster of high potency products," said Michelle Morin, Brand Manager. She continued, "Since launching in Ontario in February, Hash Bats have already become one of our fastest growing products for Good Supply."
Hash Bats™ are made to provide consumers with an elevated and uncompromisable experience, maintaining the brand's high-quality pre-roll standards with an even increased potency level for that extra impact. At 0.5g, the size helps to minimize resin build & harshness so that consumers aren't compromising on the smoking experience for higher potency, with an extra hit of hash.
Good Supply is one of Canada's leading cannabis brands in flower and vapes and a long-time favorite among consumers and budtenders. Hash Bats™ hit the market this January and has SKUs in select markets, with further anticipated national release in April and May of this year. Good Supply Hash Bats™ are for the heavy hitters, a high potency option for those looking for a higher THC range coming in at 26%, a 5% higher THC content than the average non-infused pre-roll. Hash Bats™ are available in select markets across Canada in 0.5g size pre-rolls, the perfect size for that smooth hit.
For more information, visit www.goodsupplycannabis.com and follow @goodsupplycannabis. Consumers will have the opportunity to experience the hard hit of Hash Bats in several retail locations leading up to 4/20
Tetra Bio-Pharma Inc. (TSX: TBP) (OTCQB: TBPMF), a leader in cannabinoid-derived drug discovery and development announced today that Health Canada approved the amendment of a phase I study conducted in collaboration with Dr. Jutras-Aswad and the University of Montreal Hospital Research Centre (Centre de recherche du Centre hospitalier de l'Université de Montréal, ("CRCHUM"). The study will assess the safety profile of low and moderate doses of inhaled CBD and determine the cognitive, behavioral, and biological effects of CBD in adults who occasionally use cannabis. The clinical trial has been authorized by Health Canada, who also recently approved an amendment to the research protocol to increase the dosage of the study drug up to 100 mg of CBD to be assessed in the study.
Under the collaboration, Tetra will supply the synthetic cannabidiol investigational drug products and placebo and in exchange will gain access to clinical data collected in the study. The data will include safety, pharmacokinetic, and pharmacodynamic in humans exposed to Tetra's inhaled CBD product.
Guy Chamberland, CEO and Chief Regulatory Officer of Tetra, commented, "we are very pleased to pursue our collaboration with Dr. Jutras-Aswad and the CRCHUM. Dr. Jutras-Aswad is a reference in cannabinoid research, addiction, and mental health. His research meets a public heath need to better understand the impact of cannabinoid use in human health. Together with Dr. Jutras-Aswad and the CRCHUM, one of the largest biomedical and healthcare research centres in Canada, we will advance clinical research and cannabis science in Canada."
Dr. Jutras-Aswad commented, ''there is an urgent need to accelerate the research effort to provide accurate information about the effects of cannabinoids and cannabis. This study will be critical to clarify the psychological, cognitive, and biological effects of CBD at doses that are commonly used by consumers. The approval from Health Canada is a major step in achieving these goals.''
Finally, we at Truckers. In a recent article from Business Insider, while the grueling lifestyle and aging workforce has led to a national shortage of truck drivers, a Wells Fargo executive believes there's another issue exacerbating the labor crunch — marijuana testing.
According to Chris Harvey, Wells Fargo's head of equity strategy, drug screenings paired with the nature of the job — which often requires truckers to spend weeks-on-end away from home — has led many truck drivers to leave the industry. Harvey said the issue will "continue to push that price even higher," worsening a surge in transportation costs that have left consumers facing price hikes and shortages.
"It's really about drug testing," Harvey said, speaking at an industry conference on Wednesday. "We've legalized marijuana in some states but, obviously, not all ... What we've done is we're excluding a significant portion of that trucker industry."
The role of marijuana testing in employee screening has been under debate in recent years, especially as the labor shortage continues to place more power in the hands of workers. At the same time, marijuana use has become more accepted: Last year, a Gallup poll of consumer habits found that 49% of US adults have used the drug at least once. To date, 37 states have legalized the use of cannabis for medical purposes, while 18 have cleared the substance for recreational use.
But, in recent years, the trucking industry's drug policies have become even more stringent. Truck drivers are randomly drug tested on a quarterly basis, as well as in the event of an accident or traffic ticket, according to the Federal Motor Carrier Safety Administration. Drivers that test positive are immediately removed from driving commercial motor vehicles, per the FMCSA.
In 2020, the trucking industry implemented a law that required all truck drivers who had failed a drug test to be listed in a federal database so that other trucking companies would avoid hiring the drivers. Previously, drivers could theoretically move to a new company that would not have knowledge of the positive drug test.
The law has impacted nearly 110,000 truckers, about 56% of which were reported for marijuana use, according to government data from December 2021. These 60,000 drivers who tested positive for marijuana use in the past two years could help plug the shortage of about 80,000 truckers that the American Trucking Association has reported.
Since the database was launched, more than 6.4 million queries have been conducted on the site as of late December, as all employers must consult the database before they approve a new driver. As of December, more than 81,000 drivers were "prohibited" from work — over 75% of which had not begun the lengthy reassessment process required before they can return to duty.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio , Google Podcasts and most audio platforms available.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research , guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Subscribe to:
Posts (Atom)